These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 29508538

  • 1. Does the tumour microenvironment alter tumorigenesis and clinical response in transmissible venereal tumour in dogs?
    Ballestero Fêo H, Montoya Flórez L, Yamatogi RS, Prado Duzanski A, Araújo JP, Oliveira RA, Rocha NS.
    Vet Comp Oncol; 2018 Sep; 16(3):370-378. PubMed ID: 29508538
    [Abstract] [Full Text] [Related]

  • 2. Canine transmissible venereal tumour: a morphological and immunohistochemical study of 11 tumours in growth phase and during regression after chemotherapy.
    Gonzalez CM, Griffey SM, Naydan DK, Flores E, Cepeda R, Cattaneo G, Madewell BR.
    J Comp Pathol; 2000 May; 122(4):241-8. PubMed ID: 10805977
    [Abstract] [Full Text] [Related]

  • 3. Combination therapy using intratumoral bacillus Calmette-Guerin (BCG) and vincristine in dogs with transmissible venereal tumours: therapeutic efficacy and histological changes.
    Mukaratirwa S, Chitanga S, Chimatira T, Makuleke C, Sayi ST, Bhebhe E.
    J S Afr Vet Assoc; 2009 Jun; 80(2):92-6. PubMed ID: 19831270
    [Abstract] [Full Text] [Related]

  • 4. Canine transmissible venereal tumour: a review.
    Ganguly B, Das U, Das AK.
    Vet Comp Oncol; 2016 Mar; 14(1):1-12. PubMed ID: 23981098
    [Abstract] [Full Text] [Related]

  • 5. Intratumoral recombinant human interferon alpha-2a and vincristine combination therapy in canine transmissible venereal tumour.
    Kanca H, Tez G, Bal K, Ozen D, Alcigir E, Atalay Vural S.
    Vet Med Sci; 2018 Nov; 4(4):364-372. PubMed ID: 30117719
    [Abstract] [Full Text] [Related]

  • 6. Canine transmissible venereal tumor: First report of three clinical cases from Tripoli, Libya.
    Hiblu MA, Khabuli NM, Gaja AO.
    Open Vet J; 2019 Jul; 9(2):103-105. PubMed ID: 31360646
    [Abstract] [Full Text] [Related]

  • 7. Cell-mediated immunity and expression of MHC class I and class II molecules in dogs naturally infected by canine transmissible venereal tumor: Is there complete spontaneous regression outside the experimental CTVT?
    do Prado Duzanski A, Flórez LMM, Fêo HB, Romagnoli GG, Kaneno R, Rocha NS.
    Res Vet Sci; 2022 Jul; 145():193-204. PubMed ID: 35240476
    [Abstract] [Full Text] [Related]

  • 8. Interactions of host IL-6 and IFN-gamma and cancer-derived TGF-beta1 on MHC molecule expression during tumor spontaneous regression.
    Hsiao YW, Liao KW, Chung TF, Liu CH, Hsu CD, Chu RM.
    Cancer Immunol Immunother; 2008 Jul; 57(7):1091-104. PubMed ID: 18259750
    [Abstract] [Full Text] [Related]

  • 9. Vincristine and ivermectin combination chemotherapy in dogs with natural transmissible venereal tumor of different cyto-morphological patterns: A prospective outcome evaluation.
    Ferreira Bulhosa L, Estrela-Lima A, da Silva Solcà M, Diniz Gonçalves GS, Larangeira DF, de Pinho FA, Barrouin-Melo SM.
    Anim Reprod Sci; 2020 May; 216():106358. PubMed ID: 32414469
    [Abstract] [Full Text] [Related]

  • 10. Transmissible venereal tumor: a retrospective study of 29 cases.
    Rogers KS, Walker MA, Dillon HB.
    J Am Anim Hosp Assoc; 1998 May; 34(6):463-70. PubMed ID: 9826280
    [Abstract] [Full Text] [Related]

  • 11. Predictive factors for the regression of canine transmissible venereal tumor during vincristine therapy.
    Scarpelli KC, Valladão ML, Metze K.
    Vet J; 2010 Mar; 183(3):362-3. PubMed ID: 19109042
    [Abstract] [Full Text] [Related]

  • 12. Computerized Cytomorphometric and Cytomorphological Analysis of Canine Transmissible Venereal Tumours.
    Setthawongsin C, Tangkawattana S, Rungsipipat A, Techangamsuwan S.
    J Comp Pathol; 2018 Aug; 163():18-22. PubMed ID: 30213369
    [Abstract] [Full Text] [Related]

  • 13. Primary intranasal transmissible venereal tumour in the dog: a retrospective study of six spontaneous cases.
    Papazoglou LG, Koutinas AF, Plevraki AG, Tontis D.
    J Vet Med A Physiol Pathol Clin Med; 2001 Sep; 48(7):391-400. PubMed ID: 11599677
    [Abstract] [Full Text] [Related]

  • 14. Cell cycle kinetics, apoptosis rates and gene expressions of MDR-1, TP53, BCL-2 and BAX in transmissible venereal tumour cells and their association with therapy response.
    Flórez MM, Fêo HB, da Silva GN, Yamatogi RS, Aguiar AJ, Araújo JP, Rocha NS.
    Vet Comp Oncol; 2017 Sep; 15(3):793-807. PubMed ID: 26879698
    [Abstract] [Full Text] [Related]

  • 15. A Clinico-pathological study on the effect of vincristine on transmissible venereal tumour in dogs.
    Nak D, Nak Y, Cangul IT, Tuna B.
    J Vet Med A Physiol Pathol Clin Med; 2005 Sep; 52(7):366-70. PubMed ID: 16109105
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effects of immunotherapy of IL-6 and IL-15 plasmids on transmissible venereal tumor in beagles.
    Chou PC, Chuang TF, Jan TR, Gion HC, Huang YC, Lei HJ, Chen WY, Chu RM.
    Vet Immunol Immunopathol; 2009 Jul 15; 130(1-2):25-34. PubMed ID: 19200609
    [Abstract] [Full Text] [Related]

  • 18. The changing global distribution and prevalence of canine transmissible venereal tumour.
    Strakova A, Murchison EP.
    BMC Vet Res; 2014 Sep 03; 10():168. PubMed ID: 25186078
    [Abstract] [Full Text] [Related]

  • 19. Primary transmissible venereal tumour in the nasal cavity of a dog.
    Ginel PJ, Molleda JM, Novales M, Martín E, Margarito JM, López R.
    Vet Rec; 1995 Mar 04; 136(9):222-3. PubMed ID: 7771073
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.